Intercept Pharmaceuticals Inc (ICPT)
NASDAQ
Fin d'année 31 Décembre 2022 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -49.77 | -59.187 | -58.903 | -62.252 | -54.536 | -41.169 | -16.51 | 41.049 |
Return on Equity (%) | -54.362 | -90.031 | -217.535 | -1741.424 | -975.245 | 476.821 | 52.122 | -488.125 |
Return on Invested Capital (%) | -55.449 | -65.224 | -67.91 | -78.62 | -66.293 | -48.88 | -15.503 | -21.18 |
Operating Margin (%) | -8139.073 | -1597.667 | -252.83 | -155.013 | -120.45 | -72.54 | -10.182 | -53.716 |
Net Profit Margin (%) | -8139.073 | -1654.563 | -275.182 | -171.988 | -136.777 | -87.908 | -25.154 | 77.637 |
Book Value Per Share | 9.545 | 4.737 | 0.245 | 0.268 | 0.692 | -2.234 | -2.582 | 1.119 |
Earnings Per Share | -3.589 | -6.209 | -5.391 | -4.333 | -4.625 | -3.681 | -1.283 | 2.666 |
Cash Per Share | 0.519 | 0.657 | 1.047 | 0.606 | 0.94 | 0.779 | 1.189 | 0.607 |
Working Capital Per Share | 9.421 | 9.466 | 5.151 | 5.16 | 7.506 | 4.91 | 4.709 | 3.727 |
Operating Profit Per Share | 0.044 | 0.375 | 1.939 | 2.484 | 3.325 | 4.116 | 5.059 | 3.423 |
EBIT Per Share | -3.589 | -6.209 | -5.391 | -4.333 | -4.625 | -3.681 | -1.283 | -2.102 |
EBITDA Per Share | -3.589 | -6.209 | -5.391 | -4.333 | -4.625 | -3.681 | -1.283 | -2.102 |
Free Cash Flow Per Share | -3.522 | -6.19 | -5.305 | -4.395 | -4.659 | -3.67 | -1.32 | 2.637 |
Fin d'année 31 Décembre 2022 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 21,42M | 24,82M | 25,17M | 29,69M | 32,85M | 33,02M | 29,57M | 41,52M |
Fin d'année 31 Décembre 2022 | Déc 2021 | Mar 2022 | Juin 2022 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 29,57M | 29,71M | 29,8M | 41,42M | 41,52M | 41,69M | 41,78M | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -11.979 | N/A | N/A | N/A | -42.779 | N/A | N/A |
Net Profit Margin (%) | N/A | -19.512 | N/A | N/A | N/A | -47.287 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 794,69M |
Ratio cours/bénéfice | 3,58 |
Ratio prix/ventes | 2,78 |
Ratio prix/liquidités | 15,73 |
Ratio prix/valeur comptable | 8,54 |
Rendement de dividende | - |
Actions en circulation | 41,83M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | - |
Plus haut sur 52 semaines | - |
Plus bas sur 52 semaines | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales